all

Emphasizes the Importance of LDL-Cholesterol Monitoring, LDL Goal Attainment and Shared Decision Making Between Patients and Provider

NEW YORK — Yesterday, the National Lipid Association (NLA) released the Full Report of its Part One Recommendations for Patient-Centered Management of Cholesterol based on a panel of independent experts, published in the Journal of Clinical Lipidology. The Full Report follows the Executive Summary that was released in September 2014 that incorporated feedback from key stakeholders.

Expert Panel Re-affirms the Importance of Setting Cholesterol Goals for the Prevention of Heart Attack and Stroke

The NLA expert panel’s consensus emphasizes that non-HDL-C is a better primary target for modification than LDL-C, and is now considered as a co-target with LDL-C.

The main conclusions of the NLA panel include:

1. An elevated level of cholesterol carried by circulating apolipoprotein (apo) B-containing lipoproteins (non–HDL-C and LDL-C, termed atherogenic cholesterol) is a root cause of atherosclerosis, the key underlying process contributing to most clinical arteriosclerotic cardiovascular disease (ASCVD) events.